已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study

医学 依杜沙班 阿司匹林 氯吡格雷 内科学 麻醉 药理学 胃肠病学 心脏病学 拜瑞妥 华法林 心房颤动
作者
Francesco Franchi,Fabiana Rollini,Emilio Gómez García,Jose Ramon Rivas Rios,Andrea Rivas,Malhar Agarwal,Megha Kureti,Deepa Nagaraju,Mustafa Wali,Maryuri Briceno,Jae Youn Moon,Victor Kairouz,DMITRY M. YARANOV,Latonya F. Been,Siva Suryadevara,Daniel E. Soffer,Martin M. Zenni,Theodore A. Bass,Dominick Joseph Angiolillo
出处
期刊:Thrombosis and Haemostasis [Thieme Medical Publishers (Germany)]
卷期号:120 (01): 083-093 被引量:29
标识
DOI:10.1055/s-0039-1695772
摘要

Abstract In patients requiring dual antiplatelet therapy (DAPT) who also have an indication to be treated with oral anticoagulant (OAC) drugs, aspirin withdrawal reduces the risk of bleeding. There is limited data on the pharmacodynamic effects associated with adding a nonvitamin K antagonist OAC on a background of aspirin and a P2Y12 inhibitor as well as dropping aspirin. Seventy-five patients on DAPT (aspirin plus clopidogrel) were randomized to DAPT plus high-dose edoxaban (60 mg once daily, Group A), DAPT plus low-dose edoxaban (30 mg once daily, Group B), or DAPT only (Group C) for 10 ± 2 days (Phase I). Afterwards, Groups A and B interrupted aspirin and maintained clopidogrel plus edoxaban for 10 ± 2 days, while patients in Group C maintained DAPT (Phase II). Platelet aggregation and clot kinetics were assessed at baseline, end of Phase I, and end of Phase II using thrombelastography (TEG), light transmittance aggregometry (LTA), VerifyNow P2Y12, and serum thromboxane-B2. The primary endpoint was the comparison of maximum amplitude (MA) measured by TEG, a measure of clot strength, between patients on DAPT plus high-dose edoxaban and patients on DAPT only. Edoxaban prolonged in a dose-dependent manner speed of thrombin generation (TEG R; Group A: 7.7 [6.8–8.7] vs. Group B: 7.4 [6.4–8.5] vs. Group C: 6.3 [5.7–7.0]; p = 0.05) but did not affect other markers of clot kinetics, including TEG MA (Group A: 63 [61–64] vs. Group B: 65 [63–67] vs. Group C: 64 [63–65]; p = 0.10). After aspirin discontinuation, platelet reactivity assessed by LTA using thrombin receptor activating peptide as agonist increased to a greater extent with low-dose edoxaban. Stopping aspirin did not affect markers of P2Y12 reactivity and had no or marginal effects on clot kinetics, but increased markers sensitive to cyclooxygenase-1 blockade.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
天天快乐的应助被刘旺采纳,获得30
1秒前
2秒前
大模型的应助被wise111采纳,获得10
3秒前
我是老大的应助被开心的中心采纳,获得10
7秒前
科研通AI6.3的应助被皮在痒采纳,获得10
7秒前
may完成签到 ,获得积分10
8秒前
8秒前
choin6688_完成签到 ,获得积分10
9秒前
了U完成签到 ,获得积分10
9秒前
10秒前
wise111发布了新的文献求助10
12秒前
脑洞疼的应助被le采纳,获得10
14秒前
行走的鱼发布了新的文献求助10
15秒前
16秒前
16秒前
欧克完成签到 ,获得积分10
18秒前
18秒前
AAA院士杰青批发完成签到,获得积分10
18秒前
JamesPei的应助被微笑鹤采纳,获得10
19秒前
histamin完成签到,获得积分10
22秒前
23秒前
23秒前
24秒前
Nan发布了新的文献求助10
26秒前
拥抱完成签到 ,获得积分10
26秒前
27秒前
往事发布了新的文献求助10
27秒前
领导范儿的应助被wise111采纳,获得10
28秒前
皮在痒发布了新的文献求助10
29秒前
30秒前
NexusExplorer的应助被Nan采纳,获得10
31秒前
32秒前
小丸子完成签到,获得积分10
34秒前
初景发布了新的文献求助10
35秒前
微笑鹤完成签到,获得积分10
36秒前
鱼鱼鱼完成签到 ,获得积分10
37秒前
火星上蜜粉完成签到,获得积分10
40秒前
41秒前
41秒前
42秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179640
求助须知:如何正确求助?哪些是违规求助? 9569910
关于积分的说明 21807611
捐赠科研通 7775123
什么是DOI,文献DOI怎么找? 3433072
关于科研通互助平台的介绍 2557032
邀请新用户注册赠送积分活动 2478768